Reuters logo
BRIEF-Intellipharmaceutics announces patent litigation by Purdue against its Rexista abuse-deterrent extended-release Oxycodone
April 10, 2017 / 12:11 PM / 7 months ago

BRIEF-Intellipharmaceutics announces patent litigation by Purdue against its Rexista abuse-deterrent extended-release Oxycodone

April 10 (Reuters) - Intellipharmaceutics International Inc :

* Intellipharmaceutics announces patent litigation by purdue against its Rexista™ abuse-deterrent extended-release Oxycodone

* Intellipharmaceutics International - on April 7, Purdue, plaintiffs alleged that Rexista infringes six (6) out of sixteen (16) patents Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below